9 results
10-K
2020 FY
NEXI
Neximmune Inc
31 Mar 21
Annual report
4:02pm
for one year, on a renewable basis. The holder will be required to complete ongoing studies or to conduct new studies with a view to confirming
424B4
NEXI
Neximmune Inc
16 Feb 21
Prospectus supplement with pricing info
4:38pm
to public-health threats.
Conditional marketing authorizations are valid for one year, on a renewable basis. The holder will be required to complete
S-1/A
tvyxdfo
8 Feb 21
IPO registration (amended)
7:29am
S-1
54zia5enxaezxkvqmfg
19 Jan 21
IPO registration
4:38pm
DRS/A
hp2fhte
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
bfh8269zwp7e
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next